From: Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis
Subgroup | No. of studies | No. of patients | HR (95% CI) | P value | Heterogeneity | |
---|---|---|---|---|---|---|
I2(%) | Ph | |||||
Overall | 8 | 5368 | 0.63 (0.50–0.80) | < 0.001 | 65.9 | 0.005 |
Ethnicity | ||||||
Asian | 2 | 422 | 0.46 (0.25–0.87) | 0.016 | 73.3 | 0.023 |
Caucasian | 5 | 4946 | 0.80 (0.71–0.89) | < 0.001 | 8.2 | 0.360 |
Disease stage | ||||||
Early | 2 | 536 | 0.61 (0.20–1.82) | 0.377 | 0 | 0.705 |
Mixed | 6 | 4832 | 0.63 (0.49–0.80) | < 0.001 | 75.3 | 0.001 |
Treatment | ||||||
Surgery | 4 | 4878 | 0.81 (0.74–0.89) | < 0.001 | 0 | 0.883 |
Mixed | 4 | 482 | 0.45 (0.27–0.73) | 0.001 | 62.3 | 0.047 |
Cut-off for LMR | ||||||
≥ 3 | 5 | 4930 | 0.56 (0.35–0.88) | 0.011 | 76.6 | 0.002 |
< 3 | 3 | 438 | 0.65 (0.41–1.04) | 0.075 | 41.7 | 0.180 |
Analysis method | ||||||
Univariate | 2 | 185 | 0.46 (0.27–0.79) | 0.005 | 0 | 0.488 |
Multivariate | 6 | 5183 | 0.67 (0.53–0.86) | 0.001 | 65.9 | 0.005 |